4HW2 image
Entry Detail
PDB ID:
4HW2
Title:
Discovery of potent Mcl-1 inhibitors using fragment-based methods and structure-based design
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2012-11-07
Release Date:
2013-01-09
Method Details:
Experimental Method:
Resolution:
2.80 Å
R-Value Free:
0.24
R-Value Work:
0.21
R-Value Observed:
0.21
Space Group:
P 21 21 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Induced myeloid leukemia cell differentiation protein Mcl-1
Chain IDs:A, B, C, D, E, F
Chain Length:153
Number of Molecules:6
Biological Source:Homo sapiens
Primary Citation
Discovery of potent myeloid cell leukemia 1 (Mcl-1) inhibitors using fragment-based methods and structure-based design.
J.Med.Chem. 56 15 30 (2013)
PMID: 23244564 DOI: 10.1021/jm301448p

Abstact

Myeloid cell leukemia 1 (Mcl-1), a member of the Bcl-2 family of proteins, is overexpressed and amplified in various cancers and promotes the aberrant survival of tumor cells that otherwise would undergo apoptosis. Here we describe the discovery of potent and selective Mcl-1 inhibitors using fragment-based methods and structure-based design. NMR-based screening of a large fragment library identified two chemically distinct hit series that bind to different sites on Mcl-1. Members of the two fragment classes were merged together to produce lead compounds that bind to Mcl-1 with a dissociation constant of <100 nM with selectivity for Mcl-1 over Bcl-xL and Bcl-2. Structures of merged compounds when complexed to Mcl-1 were obtained by X-ray crystallography and provide detailed information about the molecular recognition of small-molecule ligands binding Mcl-1. The compounds represent starting points for the discovery of clinically useful Mcl-1 inhibitors for the treatment of a wide variety of cancers.

Legend

Protein

Chemical

Disease

Primary Citation of related structures